| Obesity as a Disease - Our Position |
Total Body Balance |
Terms and Measuring Sticks |
| Weight Loss Programs Available | Reverse Heart Disease Now Home Page | |
| Articles About Our Program | Heartfixer Welcome Page | |
| Case Studies - 1st 25 Patients |
at |
Comprehensive Heart Care Home Page |
| New Patient Information | Medical Topics Section | |
| Total Body Balance Home Page |
Outcome Statistics
This page presents our outcomes in graphic form. Please refer to the Case Studies page for information regarding the treatment response and course of our first 25 patients.
Group Results - First 450 Female and First 180 Male
Patients to complete an Initial Course of Modified hCG Therapy


One Hundred Fifty Female Patients have completed Two Courses of Modified hCG Therapy
Total loss refers to the sum of weight loss in the two cycles combined and net
loss refers to baseline minus final weight.
Some patients were less adherent to the
protocol during round two and many utilized the 26 day protocol - their results
are included. their


Thirty
Six Female Patients have completed Three Courses of Modified hCG Therapy
Total loss refers to the sum of weight loss in the two cycles combined and net
loss refers to baseline minus final weight.
Some patients were less adherent to the
protocol during round two and/or utilized the 26 day protocol - their results
are included. the


Fifty
Three Male Patients completed Two Courses of Modified hCG Therapy
Total loss refers to the sum of weight loss in the two cycles combined and net
loss refers to baseline minus final weight.
Some patients were less adherent to the protocol during round two and/or
utilized the 26 day protocol - their results are included. t
he


Seven Male Patients have completed Three Courses of Modified hCG Therapy
Total loss refers to the sum of weight loss in the two cycles combined and net
loss refers to baseline minus final weight.
Some patients were less adherent to the
protocol during round two and/or utilized the 26 day protocol - their results
are included. the


Weight Loss by Female and Male Treatment Groups (30 Female and 10
Male Patients per Group)


Thirty Five Women completed a
23 Day
Course of Modified hCG Therapy
In some patients this was a round two or a round three
following an initial 43 day program.


Fifteen Men have completed a
23 Day Initial
Course of Modified hCG Therapy


First Ten Female Patients who have completed an Initial Course of Modified hCG
Therapy


First Ten Male Patients who have completed an
Initial Course of Modified hCG Therapy

Second Ten Male Patients who have completed an Initial Course of Modified hCG Therapy

Second Ten Female Patients who have completed an Initial Course of Modified hCG
Therapy

Third Group of Ten Male Patients
to complete an Initial Course of Modified hCG Therapy


Third
Group of Ten Female Patients to complete an Initial Course of Modified hCG
Therapy

Fourth Group of Ten Male Patients
to complete an Initial Course of Modified hCG Therapy


Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Fifth Group of Ten Male
Patients to complete an Initial Course of Modified hCG Therapy


Fifth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Sixth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy


Sixth Group of Ten Female
Patients to complete an Initial Course of Modified hCG Therapy


Seventh and Eighth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy


Ninth and Tenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy


Seventh Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Ninth Group of Ten Female
Patients to complete an Initial Course of Modified hCG Therapy


Tenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Eleventh and Twelfth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy


Eleventh Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Twelfth Group of Ten Female
Patients to complete an Initial Course of Modified hCG Therapy


Thirteenth and Fourteenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy


Thirteenth and Fourteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Fifteenth and Sixteenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy


Fifteenth and Sixteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Fifteenth and Sixteenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy


Seventeenth and Eighteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Nineteenth and Twentieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Twenty First and Twenty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Twenty Third and Twenty Fourth
Group of Ten Female Patients to complete an Initial Course of Modified hCG
Therapy


Twenty Fifth and Twenty Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Twenty Seventh and Twenty Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Twenty Ninth and Thirtieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Thirty First and Thirty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Thirty Third and Thirty Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Thirty Fifth and Thirty Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Thirty Seventh and Thirty Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Thirty Ninth and Fortieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Forty First and Forty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Forty Third and Forty Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


Forty Fifth and Forty Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy
Patients with Limited Adherence to the Diet
Most of our patients followed the diet to the letter - and then were rewarded with a significant weight loss. Others followed the diet most of the time, breaking away occasionally in relation to hunger or social obligations (we are all human); their statistics are included in the overall results. Excluded from the main statistics and presented below are patients who did not follow the program most of the time. As you can see, when you do not follow Dr. Simeons' guidelines you do not obtain a significant reduction in weight.

Early Discontinuation
A small number of patients (»10% of those who
start) stopped early or dropped out of the program for the
reasons given below.
| Patient | Reason | Patient | Reason |
| W1dc | Hunger; Lost Motivation | M1dc | Prostatitis |
| W2dc | Hunger | M2dc | Fever and URI |
| W3dc | No Return Call | M3dc | Disc Disease Flare Up |
| W4dc | Lost hCG | M4dc | No Return Call |
| W5dc | Lost Motivation | M5dc | Hunger & Frustration |
| W6dc | Schedule Conflict | M6dc-2 | Lost Motivation Round Two |
| W7dc | Lost Motivation | M7dc | No Return Call |
| W8dc | Possible Allergy | M8dc | Diverticular Disease |
| W9dc | No Return Call | M9dc-2 | Lost Motivation Round Two |
| W10dc-2 | Lost Motivation Round 2 | M10dc | No Return Call |
| W11c | No Return Call | M11dc | Broke Rules & Quit |
| W12dc | Surgery Required | M12dc | Lost Motivation |
| W13dc | Lost Motivation | M13dc-2 | Broke Rules & Quit |
| W14dc | Quit | M14dc-2 | Friend Died |
| W15dc-2 | Lost Motivation Round 2 | M15dc | Quit |
| W16dc-2 | Lost Motivation Round 2 | M16dc | Quit |
| W17dc | Quit | M17dc-2 | Lost Motivation Round 2 |
| W18dc | Caught a cold | M18dc-2 | Lost Motivation Round 2 |
| W19dc | Caught a cold | M19dc-4 | Lost Motivation Round 4 |
| W20dc | No Return Call | M20dc | Back Issues |
| W21dc | Lost Motivation | W44dc | Quit |
| W22dc | Quit | W45dc | Quit |
| W23dc | Quit | W46dc-2 | Lost Motivation Round 2 |
| W24dc-3 | Lost Motivation Round 3 | W47dc | Quit |
| W25dc | Lost Motivation | W48dc-2 | Pneumonia |
| W26dc-2 | Lost Motivation Round 2 | W49dc-2 | Lost Motivation Round 2 |
| W27dc-2 | Lost Motivation Round 2 | W50dc | Quit |
| W28dc-3 | Lost Motivation Round 3 | W51dc-2 | Lost Motivation Round 2 |
| W29dc | Lost Motivation | W52dc | Quit |
| W30dc | No Return Call | W53dc | Quit |
| W31dc-2 | Quit | W54dc | Family Problems |
| W32dc-2 | Refused Office Visits | W55dc | Quit at Two Weeks |
| W33dc | Migraine Headache | W56dc-2 | Family Problems |
| W34dc | Quit | W57dc | No Show/No Response |
| W35dc | Quit | W58dc | Colon Issues |
| W36dc-2 | Lost Motivation Round 2 | W59dc | Quit at Two Weeks |
| W37dc | Quit | W60dc-2 | Lost Motivation Round 2 |
| W38dc | Quit | W61dc-2 | Lost Motivation Round 2 |
| W39dc | Quit | W62dc-3 | Lost Motivation Round 3 |
| W40dc-2 | Quit Round 2 | W63dc-2 | Lost Motivation Round 2 |
| W41dc | Quit | W64dc | Quit |
| W42dc | Quit | W65dc | Quit |
| W43dc | Quit | W66dc | No Show/No Response |
| W44dc | No Show | W67dc | No Show/No Response |
| W45dc | No show | W68dc | Pregnancy |
| W42dc | No Show | W69dc | Quit |
| W43dc | Quit | W70dc | Quit |
| W71dc | Quit | W77dc | Quit |
| W72dc | Quit | W78dc-2 | Lost Motivation Round 2 |
| W73dc-3 | Lost Motivation Round 3 | W79dc-2 | Lost Motivation Round 2 |
| W74dc-2 | W80dc-2 | Pregnancy | |
| W75dc-2 | Family Stress | W81dc-2 | Lost Motivation Round 2 |
| W76dc-2 | W82dc-3 | Lost Motivation Round 3 |
Our quit rate for round one is 12% for women and 7% for men. Patients who dropped out or stopped early did so primarily due to loss of motivation and/or hunger. We did not feel that the hCG program was the cause of M1dc's prostatitis, M3dc's disc disease flare up, M8dc's diverticular disease, or M2dc's upper respiratory tract infection. However, 10 days later M2dc experienced gall bladder inflammation, leading to cholycystectomy (surgical removal of the gall bladder). W98 also required cholycystectomy towards the end of her 40 day program. A third patients required cholycystectomy eight weeks after completion the program. Rapid weight reduction by any means can lead to inflammation within the gall bladder (probably only in individuals with pre-existent gall bladder disease but we cannot say this with certainty). Thus our gall bladder event rate is 3 cases amongst 560 patients undergoing 833 rounds of hCG therapy (0.5% of patients treated). Two patients experienced a transient flare up of gout. These side-effects of hCG-assisted weight reduction are not unexpected and are discussed by Dr. Simeons in his book. A handful of patients experienced upper respiratory infections and stopped early; we feel this was the seasonal flu and not a direct complication of their weight loss program. Several patients who were doing well became diagnosed with an unrelated problem and had to drop out early to begin treatment. Two women dropped out early as they found they were pregnant (while risk to the baby is not expected with hCG, we advise against conceiving while on our program - one women was felt to be infertile but fertility returned with weight loss). A small number of patients developed urinary tract infection or pneumonia while on the program. These infections are likely incidental to weight loss, and not caused by weight loss. However, if significant infection occurs, we counsel you to stop hCG and immediately increase caloric intake to a Phase 3 level, emphasizing protein over carbohydrate, as 500 calories a day is not sufficient when your physiology is marshaling its resources to defend you against bacterial invasion. The program can be restarted (including the gorge days) after you have recovered.
Current Status (as of 3/26/11)
| One Full Round of Weight Reduction Completed | 400 Women and 160 Men |
|
Two Rounds Completed |
130 Women and 50 Men |
|
Three Rounds Completed |
36 Women and 7 Men |
| 26 Day Round One Completed | 35 Women and 15 Men |
|
Currently Undergoing Round One |
19 Women and 4 Men |
|
Currently Undergoing Rounds Two or Three |
26 Women and 7 Men |
|
Limited Dietary Adherence |
50 Women and 22 Men |
|
Early Discontinuation of Round One |
53 Women and 13 Men |
|
Early Discontinuation of Round Two |
22 Women and 6 Men |
|
Early Discontinuation of Subsequent Rounds |
5 Women and 1 Man |
|
Program Modified |
2 Women |
|
Cosmetic Weight Loss |
4 Women |
Please Note - It is the position of the FDA and FTC that HCG has not been demonstrated to be effective adjunctive therapy in the treatment of obesity. There is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes more attractive or “normal” distribution of fat, or that it decrease the hunger and discomfort associated with calorie-restricted diets.
